These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22404661)

  • 1. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Sánchez-Mora C; Bosch R; Bielsa A; Gastaminza X; Lesch KP; Reif A; Renner TJ; Romanos M; Warnke A; Walitza S; Freitag C; Meyer J; Palmason H; Casas M; Bayés M; Cormand B
    World J Biol Psychiatry; 2012 Apr; 13(4):281-92. PubMed ID: 22404661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci.
    Hawi Z; Lowe N; Kirley A; Gruenhage F; Nöthen M; Greenwood T; Kelsoe J; Fitzgerald M; Gill M
    Mol Psychiatry; 2003 Mar; 8(3):299-308. PubMed ID: 12660802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder.
    Ribasés M; Bosch R; Hervás A; Ramos-Quiroga JA; Sánchez-Mora C; Bielsa A; Gastaminza X; Guijarro-Domingo S; Nogueira M; Gómez-Barros N; Kreiker S; Gross-Lesch S; Jacob CP; Lesch KP; Reif A; Johansson S; Plessen KJ; Knappskog PM; Haavik J; Estivill X; Casas M; Bayés M; Cormand B
    Biol Psychiatry; 2009 Nov; 66(10):926-34. PubMed ID: 19733838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder.
    Misener VL; Luca P; Azeke O; Crosbie J; Waldman I; Tannock R; Roberts W; Malone M; Schachar R; Ickowicz A; Kennedy JL; Barr CL
    Mol Psychiatry; 2004 May; 9(5):500-9. PubMed ID: 14569274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Bosch R; Bielsa A; Gastaminza X; Artigas J; Rodriguez-Ben S; Estivill X; Casas M; Cormand B; Bayés M
    Mol Psychiatry; 2009 Jan; 14(1):71-85. PubMed ID: 17938636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Support for association between ADHD and two candidate genes: NET1 and DRD1.
    Bobb AJ; Addington AM; Sidransky E; Gornick MC; Lerch JP; Greenstein DK; Clasen LS; Sharp WS; Inoff-Germain G; Wavrant-De Vrièze F; Arcos-Burgos M; Straub RE; Hardy JA; Castellanos FX; Rapoport JL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):67-72. PubMed ID: 15717291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2.
    Nyman ES; Ogdie MN; Loukola A; Varilo T; Taanila A; Hurtig T; Moilanen IK; Loo SK; McGough JJ; Järvelin MR; Smalley SL; Nelson SF; Peltonen L
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1614-21. PubMed ID: 18030083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes.
    Carpentier PJ; Arias Vasquez A; Hoogman M; Onnink M; Kan CC; Kooij JJ; Makkinje R; Iskandar S; Kiemeney LA; de Jong CA; Franke B; Buitelaar JK
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):448-57. PubMed ID: 22841130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample.
    Fernàndez-Castillo N; Ribasés M; Roncero C; Casas M; Gonzalvo B; Cormand B
    Psychiatr Genet; 2010 Dec; 20(6):317-20. PubMed ID: 20505554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association and linkage of allelic variants of the dopamine transporter gene in ADHD.
    Friedel S; Saar K; Sauer S; Dempfle A; Walitza S; Renner T; Romanos M; Freitag C; Seitz C; Palmason H; Scherag A; Windemuth-Kieselbach C; Schimmelmann BG; Wewetzer C; Meyer J; Warnke A; Lesch KP; Reinhardt R; Herpertz-Dahlmann B; Linder M; Hinney A; Remschmidt H; Schäfer H; Konrad K; Hübner N; Hebebrand J
    Mol Psychiatry; 2007 Oct; 12(10):923-33. PubMed ID: 17579611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
    Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
    Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder.
    Bhaduri N; Mukhopadhyay K
    Neurosci Lett; 2006 Jul; 402(1-2):12-6. PubMed ID: 16616989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.